Progenity Inc. (PROG) Social Stream
Progenity Inc (PROG) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering Progenity Inc.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
PROG's average price target has moved down $3.66 over the prior 98 days.
Over the past 32 weeks, PROG's average upside potential has been 208.79%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
PROG Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
PROG's average broker recommendation rating worsened by 0.4 over the prior 123 days.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for PROG as an investment opportunity.
- To contextualize these metrics, consider that out of all US stocks, Progenity Inc's average analyst price target is greater than 2.64% of them.
- In terms of how Progenity Inc fares relative to all US stocks, note that its variance in analysts' estimates is lower than -153.59% of that group.
- To contextualize these metrics, consider that out of Healthcare stocks, Progenity Inc's number of analysts covering the stock is higher than 61.97% of them.
- Progenity Inc's upside potential (average analyst target price relative to current price) is greater than 184.74% of Healthcare stocks.
Make investment decisions regarding PROG using the data that counts. Try POWR Ratings for free.